Close Menu

NEW YORK (GenomeWeb) – Advanced Biological Laboratories will market and distribute a next-generation sequencing-based test for tuberculosis from the Translational Genomics Research Institute under a licensing deal announced today.

The test, called DeepCheck-TB, is currently available for research use only. As part of the agreement announced by TGen, ABL will distribute a compact, portable, and affordable diagnostic model that physicians can use to determine the most appropriate treatment for individual TB patients.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.